Karoly Nikolich
Founder bei Circuit Therapeutics, Inc.
Profil
Karoly Nikolich founded AGY Therapeutics, Inc. in 1998, where he worked as Chief Executive & Scientific Officer, Director from 1998 to 2005 and Circuit Therapeutics, Inc. in 2010, where he is working as President from 2010.
Dr. Nikolich also founded MapLight Therapeutics, Inc. and Hummingbird Diagnostics GmbH, where he worked as Director.
Dr. Nikolich also currently works at Alkahest, Inc., as Chairman & Chief Executive Officer from 2014, Excelimmune, Inc., as Director, NeuroTherapia, Inc., as Director from 2020, Chase Therapeutics Corp., as Director, Schaller-Nikolich Stiftung gGmbH, as Managing Director, Engrail Therapeutics, Inc., as Director, Selonterra, Inc., as Independent Director, Pivotal Bioventure Partners Investment Advisor LLC, as Venture Partner from 2017, and Nan Fung Life Sciences, as Advisor.
Dr. Nikolich also formerly worked at Amnestix, Inc., as Chief Executive Officer from 2007 to 2008, Neurofluidics, Inc., as Director & Chief Executive Officer from 2007 to 2013, Angiochem, Inc., as Chairman from 2005 to 2015, Nevis Brands, Inc., as Chairman from 2015 to 2021, Neuropore Therapies, Inc., as Chairman, Chase Pharmaceuticals Corp., as Director, Neuroscience Institute of Schizophrenia & Allied Disorders, as Executive Director, Stanford University School of Medicine, as Executive Director from 2005 to 2007, Genentech, Inc., as Head-Neuroscience Program from 1983 to 1995, Lynx Therapeutics, Inc., as Vice President-Research from 1997 to 1998, Biovail Corp., as Advisor from 2009 to 2010, Stanford University, as Professor, biOasis Technologies, Inc., as Board Member from 2013 to 2015, Axaron Bioscience AG, as Member-Supervisory Board from 1996 to 1998, and dievini Verwaltungs GmbH, as Advisor from 2007 to 2009.
Dr. Nikolich received his doctorate degree from Tulane University (Louisiana) and undergraduate degree from Eotvos Lorand University.
Aktive Positionen von Karoly Nikolich
| Unternehmen | Position | Beginn |
|---|---|---|
Circuit Therapeutics, Inc.
 Circuit Therapeutics, Inc. Medical/Nursing ServicesHealth Services Circuit Therapeutics, Inc. provides therapy and health care services. It specializes in optogenetics, gene therapy, neuromodulation and drug discovery services. The company was founded by Karl Deisseroth, Rob Malenka, Scott Delp, Thomas Sudhof and Karoly Nikolich and is headquartered in Menlo Park, CA. | Founder | 01.10.2010 |
Excelimmune, Inc.
 Excelimmune, Inc. Miscellaneous Commercial ServicesCommercial Services Excelimmune, Inc. provides laboratory and biotechnology services. It is a biopharmaceutical company specializing in the development of recombinant polyclonal antibodies to create novel therapies for treating disease in humans. The firm’s next generation technology is applicable to the treatment of diseases and infections caused by common bacteria, disease-causing proteins and viral pathogens. The company was founded in 2006 by Quinton Y. Zondervan and Vincent W. Coljee and is headquartered in Lexington, MA. | Director/Board Member | - |
Alkahest, Inc.
 Alkahest, Inc. BiotechnologyHealth Technology Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA. | Chief Executive Officer | 01.07.2014 |
Chase Therapeutics Corp.
 Chase Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chase Therapeutics Corp. operates as healthcare company. The company was founded in 2017 and is headquartered in Washington, DC. | Director/Board Member | - |
Pivotal Bioventure Partners Investment Advisor LLC
 Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Private Equity Investor | 01.01.2017 |
Engrail Therapeutics, Inc.
 Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA. | Director/Board Member | - |
NeuroTherapia, Inc.
 NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology NeuroTherapia, Inc. discovers and develops new therapies for diseases with an underlying component of neuroinflammation. The company was founded by Mohamed Naguib Attala and Joseph F. Foss in 2015 and is headquartered in Cleveland, OH. | Director/Board Member | 22.09.2020 |
Schaller-Nikolich Stiftung gGmbH
 Schaller-Nikolich Stiftung gGmbH Miscellaneous Commercial ServicesCommercial Services Schaller-Nikolich Stiftung gGmbH is a German company that engages in social work activities services. The private company is based in Heidelberg, Germany. The CEO of the company is Karoly Nikolich. | Chief Executive Officer | - |
Hummingbird Diagnostics GmbH
 Hummingbird Diagnostics GmbH Medical SpecialtiesHealth Technology Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation. | Founder | - |
| ░░░ ░░░░ ░░░░ ░░░░░░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | - |
Ehemalige bekannte Positionen von Karoly Nikolich
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Karoly Nikolich
| Tulane University (Louisiana) | Doctorate Degree |
| Eotvos Lorand University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOASIS TECHNOLOGIES INC. | Health Technology |
| NEVIS BRANDS INC. | Health Technology |
| Private Unternehmen | 24 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Lynx Therapeutics, Inc.
 Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Lynx Therapeutics, Inc. was a developer of genetic analysis products for the pharmaceutical, biotechnology and agriculture industries. It's MPSSTM instruments analyze millions of DNA molecules in parallel enabling genome structure characterization at an unprecedented level of resolution. MPSSTM provides comprehensive and quantitative digital information important to modern systems biology research in the pharmaceutical, biotechnology and agricultural industries. The company was headquartered in Hayward, CA. | Health Technology |
Biovail Corp.
 Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | Health Technology |
AGY Therapeutics, Inc.
 AGY Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AGY Therapeutics, Inc. develops new therapies for diseases and disorders. It develops central nervous system therapeutics for the treatments of neurodegenerative diseases, CNS injuries, stroke, and schizophrenia. The company was founded by Robert Swanson and Karoly Nikolich in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Amnestix, Inc.
 Amnestix, Inc. Pharmaceuticals: MajorHealth Technology Amnestix, Inc. developed therapeutics for the enhancement of cognitive functions. It focused on novel therapeutics for improving memory associated with human diseases. The company was founded by Dietrich Stephan in 2006 and was headquartered in Phoenix, AZ. | Health Technology |
Excelimmune, Inc.
Excelimmune, Inc. Miscellaneous Commercial ServicesCommercial Services Excelimmune, Inc. provides laboratory and biotechnology services. It is a biopharmaceutical company specializing in the development of recombinant polyclonal antibodies to create novel therapies for treating disease in humans. The firm’s next generation technology is applicable to the treatment of diseases and infections caused by common bacteria, disease-causing proteins and viral pathogens. The company was founded in 2006 by Quinton Y. Zondervan and Vincent W. Coljee and is headquartered in Lexington, MA. | Commercial Services |
Chase Pharmaceuticals Corp.
 Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Health Technology |
Alkahest, Inc.
Alkahest, Inc. BiotechnologyHealth Technology Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA. | Health Technology |
Angiochem, Inc.
 Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Health Technology |
Neurofluidics, Inc.
 Neurofluidics, Inc. Medical DistributorsDistribution Services Neurofluidics, Inc. develops neurological therapies. It also develops targeted and logical treatment approaches for patients suffering from neurological disorders. The company was founded in 2008 and is headquartered in Menlo Park, CA. | Distribution Services |
Axaron Bioscience AG
 Axaron Bioscience AG Miscellaneous Commercial ServicesCommercial Services Axaron Bioscience AG develops biotechnologies. The company is based in Heidelberg, Germany and has subsidiaries in Germany. | Commercial Services |
Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH Medical SpecialtiesHealth Technology Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation. | Health Technology |
| Neuroscience Institute of Schizophrenia & Allied Disorders | |
| dievini Verwaltungs GmbH | |
Circuit Therapeutics, Inc.
Circuit Therapeutics, Inc. Medical/Nursing ServicesHealth Services Circuit Therapeutics, Inc. provides therapy and health care services. It specializes in optogenetics, gene therapy, neuromodulation and drug discovery services. The company was founded by Karl Deisseroth, Rob Malenka, Scott Delp, Thomas Sudhof and Karoly Nikolich and is headquartered in Menlo Park, CA. | Health Services |
Neuropore Therapies, Inc.
 Neuropore Therapies, Inc. Medical/Nursing ServicesHealth Services Neuropore Therapies, Inc. provides biopharmaceutical services. It also offers alpha-synuclein (ASYN), amyloid beta, autophagy, and publications programs. The company was founded by Eliezer Masliah in 2008 and is headquartered in San Diego, CA. | Health Services |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Finance |
NeuroTherapia, Inc.
NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology NeuroTherapia, Inc. discovers and develops new therapies for diseases with an underlying component of neuroinflammation. The company was founded by Mohamed Naguib Attala and Joseph F. Foss in 2015 and is headquartered in Cleveland, OH. | Health Technology |
Chase Therapeutics Corp.
Chase Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chase Therapeutics Corp. operates as healthcare company. The company was founded in 2017 and is headquartered in Washington, DC. | Health Technology |
Nan Fung Life Sciences
 Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong. | Finance |
Schaller-Nikolich Stiftung gGmbH
Schaller-Nikolich Stiftung gGmbH Miscellaneous Commercial ServicesCommercial Services Schaller-Nikolich Stiftung gGmbH is a German company that engages in social work activities services. The private company is based in Heidelberg, Germany. The CEO of the company is Karoly Nikolich. | Commercial Services |
MapLight Therapeutics, Inc.
 MapLight Therapeutics, Inc. BiotechnologyHealth Technology MapLight Therapeutics, Inc. engages in the development of novel therapeutics for brain disorders. The company is headquartered in San Francisco, CA. | Health Technology |
Engrail Therapeutics, Inc.
Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA. | Health Technology |
Selonterra, Inc.
 Selonterra, Inc. BiotechnologyHealth Technology The American company focuses on developing therapies for neurodegenerative disorders such as Parkinson's and Alzheimer's disease. The company uses human genetics, molecular pathway analysis, and gene regulatory networks to identify disease-causing mechanisms and molecular targets to discover effective therapeutics. Selonterra's founders and advisors are experienced scientists and executives in the biotech and pharma industries, and they collaborate with other companies in their network. The company was founded by Anne Urfer-Buchwalder and Roman Urfer, with Roman Urfer serving as CEO since incorporation. | Health Technology |
